TY - JOUR
T1 - Epilepsy as a Network Disorder (2)
T2 - What can we learn from other network disorders such as dementia and schizophrenia, and what are the implications for translational research?
AU - Scharfman, Helen E.
AU - Kanner, Andres M.
AU - Friedman, Alon
AU - Blümcke, Ingmar
AU - Crocker, Candice E.
AU - Cendes, Fernando
AU - Diaz-Arrastia, Ramon
AU - Förstl, Hans
AU - Fenton, André A.
AU - Grace, Anthony A.
AU - Palop, Jorge
AU - Morrison, Jason
AU - Nehlig, Astrid
AU - Prasad, Asuri
AU - Wilcox, Karen S.
AU - Jette, Nathalie
AU - Pohlmann-Eden, Bernd
N1 - Funding Information:
Anthony Grace has worked with and received honoraria related to that work from Lundbeck, Pfizer, Otsuka, Lilly, Roche, Asubio, Abbott, Autofony, Janssen, Alkermes, Newron. Andre Fenton is a founder and director of Bio-Signal group Corp. Helen Scharfman received research funding from Pyramid Biosciences in 2017 and is on the Scientific Advisory Board. Asuri Prasad has received honoraria from Eisai Inc. for lectures about epilepsy. Karen Wilcox is on the Scientific Advisory Board of Blackfynn Inc. The other authors declare no conflicts of interest.
Funding Information:
Support for the authors comes from NIH R01 NS-081203, R01 MH-109305, R01 AG-055328, and the New York State Office of Mental Health (HES); IB is supported by the European Union (FP7 DESIRE grant agreement # 602531). BP received grants from the Epilepsy Association of Nova Scotia, Nova Scotia Health Research Foundation, Brain Repair Center, Dalhousie University.
Publisher Copyright:
© 2017 Elsevier Inc.
PY - 2018/1/1
Y1 - 2018/1/1
N2 - There is common agreement that many disorders of the central nervous system are ‘complex’ that is, there are many potential factors that influence the development of the disease, underlying mechanisms, and successful treatment. Most of these disorders, unfortunately, have no cure at the present time, and therapeutic strategies often have debilitating side effects. Interestingly, some of the ‘complexities’ of one disorder are found in another, and the similarities are often network defects. It seems likely that more discussions of these commonalities could advance our understanding and, therefore, have clinical implications or translational impact. With this in mind, the Fourth International Halifax Epilepsy Conference and Retreat was held as described in the prior paper, and this companion paper focuses on the second half of the meeting. Leaders in various subspecialties of epilepsy research were asked to address aging and dementia or psychosis in people with epilepsy (PWE). Commonalities between autism, depression, aging and dementia, psychosis, and epilepsy were the focus of the presentations and discussion. In the last session, additional experts commented on new conceptualization of translational epilepsy research efforts. Here, the presentations are reviewed, and salient points are highlighted.
AB - There is common agreement that many disorders of the central nervous system are ‘complex’ that is, there are many potential factors that influence the development of the disease, underlying mechanisms, and successful treatment. Most of these disorders, unfortunately, have no cure at the present time, and therapeutic strategies often have debilitating side effects. Interestingly, some of the ‘complexities’ of one disorder are found in another, and the similarities are often network defects. It seems likely that more discussions of these commonalities could advance our understanding and, therefore, have clinical implications or translational impact. With this in mind, the Fourth International Halifax Epilepsy Conference and Retreat was held as described in the prior paper, and this companion paper focuses on the second half of the meeting. Leaders in various subspecialties of epilepsy research were asked to address aging and dementia or psychosis in people with epilepsy (PWE). Commonalities between autism, depression, aging and dementia, psychosis, and epilepsy were the focus of the presentations and discussion. In the last session, additional experts commented on new conceptualization of translational epilepsy research efforts. Here, the presentations are reviewed, and salient points are highlighted.
KW - Alzheimer's disease
KW - Circuit
KW - Neurology
KW - Neuroscience
KW - Preclinical
KW - Psychosis
KW - Seizure
KW - Systems
UR - http://www.scopus.com/inward/record.url?scp=85032741081&partnerID=8YFLogxK
U2 - 10.1016/j.yebeh.2017.09.016
DO - 10.1016/j.yebeh.2017.09.016
M3 - Review article
AN - SCOPUS:85032741081
SN - 1525-5050
VL - 78
SP - 302
EP - 312
JO - Epilepsy and Behavior
JF - Epilepsy and Behavior
ER -